PDCD1LG2 and breast cancer: Given the importance of immune checkpoints for BC, we also analyzed 21 common immune checkpoints and found that PDCD1LG2, CD86, IDO1, CD276, TNFSF9, and NRP1 were higher in the high-risk populations (Figure 5H).